Literature DB >> 20697411

Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Guido Lastra1, Sonal Dhuper, Megan S Johnson, James R Sowers.   

Abstract

Hypertension and type 2 diabetes mellitus (T2DM) are powerful risk factors for cardiovascular disease (CVD) and chronic kidney disease (CKD), both of which are leading causes of morbidity and mortality worldwide. Research into the pathophysiology of CVD and CKD risk factors has identified salt sensitivity and insulin resistance as key elements underlying the relationship between hypertension and T2DM. Excess dietary salt and caloric intake, as commonly found in westernized diets, is linked not only to increased blood pressure, but also to defective insulin sensitivity and impaired glucose homeostasis. In this setting, activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS), as well as increased signaling through the mineralocorticoid receptor (MR), result in increased production of reactive oxygen species and oxidative stress, which in turn contribute to insulin resistance and impaired vascular function. In addition, insulin resistance is not limited to classic insulin-sensitive tissues such as skeletal muscle, but it also affects the cardiovascular system, where it participates in the development of CVD and CKD. Current clinical knowledge points towards an impact of salt restriction, RAAS blockade, and MR antagonism on cardiovascular and renal protection, but also on improved insulin sensitivity and glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697411     DOI: 10.1038/nrcardio.2010.123

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  74 in total

1.  Effect of arterial baroreceptor denervation on sodium balance.

Authors:  Gerald F DiBona; Linda L Sawin
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Aldosterone-sensitive neurons in the rat central nervous system.

Authors:  Joel C Geerling; Mitsuhiro Kawata; Arthur D Loewy
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

Review 4.  Aldosterone and vascular inflammation.

Authors:  Nancy J Brown
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

5.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

6.  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Authors:  Richard B Devereux; Björn Dahlöf; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine E Harris; Jonathan M Edelman; Kristian Wachtell
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

7.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

8.  Association between salt sensitivity and insulin concentrations in patients with hypertension.

Authors:  I Zavaroni; P Coruzzi; L Bonini; G L Mossini; L Musiari; P Gasparini; M Fantuzzi; G M Reaven
Journal:  Am J Hypertens       Date:  1995-08       Impact factor: 2.689

9.  A novel adipokine CTRP1 stimulates aldosterone production.

Authors:  Jun Ho Jeon; Kun-yong Kim; Jae Hyeong Kim; Ahmi Baek; Hyungin Cho; Young Ho Lee; Jong Wan Kim; Dohee Kim; Seung Hyun Han; Jong-Seok Lim; Keun Il Kim; Do Young Yoon; Soo-Hyun Kim; Goo Taeg Oh; Eunjoon Kim; Young Yang
Journal:  FASEB J       Date:  2008-01-02       Impact factor: 5.191

Review 10.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  42 in total

Review 1.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 2.  Current status of bicarbonate in CKD.

Authors:  Mirela Dobre; Mahboob Rahman; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

Review 3.  New insights into insulin action and resistance in the vasculature.

Authors:  Camila Manrique; Guido Lastra; James R Sowers
Journal:  Ann N Y Acad Sci       Date:  2014-03-20       Impact factor: 5.691

4.  Insulin resistance, obesity, hypertension, and renal sodium transport.

Authors:  Shoko Horita; George Seki; Hideomi Yamada; Masashi Suzuki; Kazuhiko Koike; Toshiro Fujita
Journal:  Int J Hypertens       Date:  2011-04-12       Impact factor: 2.420

5.  Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis.

Authors:  M Marlina Manhiani; A Daniel Duggan; Hunter Wilson; Michael W Brands
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

6.  Glucocorticoids affect metabolic but not muscle microvascular insulin sensitivity following high versus low salt intake.

Authors:  Monica Tj Schütten; Yvo Ham Kusters; Alfons Jhm Houben; Hanneke E Niessen; Jos Op 't Roodt; Jean Ljm Scheijen; Marjo P van de Waardenburg; Casper G Schalkwijk; Peter W de Leeuw; Coen DA Stehouwer
Journal:  JCI Insight       Date:  2020-03-26

7.  Effect of low salt diet on insulin resistance in salt-sensitive versus salt-resistant hypertension.

Authors:  Rajesh Garg; Bei Sun; Jonathan Williams
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

8.  Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Amanda E Garza; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2013-11-26       Impact factor: 4.030

Review 9.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

Review 10.  The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

Authors:  Atsuhisa Sato
Journal:  Hypertens Res       Date:  2015-03-12       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.